Abstract:
An improved thrombopoietin mimetic, the bis-(monoethanolamine) salt of 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid.
Abstract:
An improved thrombopoietin mimetic, the bis-(monoethanolamine) salt of 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid.
Abstract:
An improved thrombopoietin mimetic, the bis-(monoethanolamine) salt of 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid.
Abstract:
The present application concerns a coated film comprising a substantially biodegradable substrate having a biodegradable coating thereon at a coat weight of not more than 12 gsm, as well as useful articles sealed inside a package at least partly comprising such a film, and also a process for producing a coated film comprising providing a substantially biodegradable film substrate and applying a biodegradable coating to the substrate at a coat weight of less than 12 gsm by means of a hot melt coating step.
Abstract:
A system and method for use in an automated data storage cartridge library defines cartridges for use with an external host computer (“open” cartridges), and cartridges for use only internal to the library (“closed” cartridges). Cartridges may be “virtualized” by storing data from them on disk or closed cartridges, and then “realized” by writing data to physical cartridges. Virtual cartridges may be logically exported from one library to another. When new cartridges are introduced to the library, they may be designated with one of multiple designations or uses.